Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1999 Aug;37(8):2709-14.
doi: 10.1128/JCM.37.8.2709-2714.1999.

Novel immunoblot assay using four recombinant antigens for diagnosis of Epstein-Barr virus primary infection and reactivation

Affiliations
Comparative Study

Novel immunoblot assay using four recombinant antigens for diagnosis of Epstein-Barr virus primary infection and reactivation

M Buisson et al. J Clin Microbiol. 1999 Aug.

Abstract

A new immunoblot assay, composed of four Epstein-Barr virus (EBV)-encoded recombinant proteins (virus capsid antigen [VCA] p23, early antigen [EA] p138, EA p54, and EBNA-1 p72), was compared with an immunofluorescence assay on a total of 291 sera. The test was accurate in 94.5% of cases of primary EBV infection, while an immunoglobulin G anti-VCA p23 band with strong intensity correlated with reactivation.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
EBV IF interpretation algorithm established from routine laboratory experience. ∗, if the VCA IgG titer is ≥1,280, there is possible reactivation or chronic infection; ∗∗, if the EA IgG titer is ≥80, there is possible reactivation.
FIG. 2
FIG. 2
EBV blot interpretation algorithm established by this study. ∗, if the VCA p23 IgG titer is ≥3+, there is possible reactivation without EBNA. If there is a band intensity of 3+ or less, refer to IgM control band intensity of IgM assay.

Similar articles

Cited by

References

    1. Debyser Z, Reynders M, Goubau P, Desmyter J. Comparative evaluation of three ELISA techniques and an indirect immunofluorescence assay for the serological diagnosis of Epstein-Barr virus infection. Clin Diagn Virol. 1997;8:71–81. - PubMed
    1. Färber I, Wutzler P, Wohlrabe P, Wolf H, Hinderer W, Sonneborn H-H. Serological diagnosis of infectious mononucleosis using three anti-Epstein-Barr virus recombinant ELISAs. J Virol Methods. 1993;42:301–308. - PubMed
    1. Fleisher G, Lennette E T, Henle G, Henle W. Incidence of heterophil antibody responses in children with infectious mononucleosis. J Pediatr. 1979;94:723–728. - PubMed
    1. Gorgievski-Hrisoho M, Hinderer W, Nebel-Schickel H, Horn J, Vornhagen R, Sonneborn H-H, Wolf H, Siegl G. Serodiagnosis of infectious mononucleosis by using recombinant Epstein-Barr virus antigens and enzyme-linked immunosorbent assay technology. J Clin Microbiol. 1990;28:2305–2311. - PMC - PubMed
    1. Henle G, Henle W. Immunofluorescence in cells derived from Burkitt’s lymphoma. J Bacteriol. 1966;91:1248–1256. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources